Everything's Special At US FDA: Priority NDA/BLA Filings Surge
The FY 2018 PDUFA performance report also indicates that applications with standard assessments fell compared to long-term averages.
The FY 2018 PDUFA performance report also indicates that applications with standard assessments fell compared to long-term averages.